Clinical Trial Update: The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a combination of HBIG, GM-CSF, and hepatitis B vaccine in chronic hepatitis B patients with HBeAg seroconversion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• HBIG (hepatitis B immune globulin)
• HBV vaccine (hepatitis B vaccine)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: UNKNOWN